Crestline Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-22,000
Closed -$611K 98
2019
Q2
$611K Buy
+22,000
New +$611K 0.08% 68